AZERIA THERAPEUTICS LIMITED
BERKHAMSTED

Hellopages » Hertfordshire » Dacorum » HP4 2AF
Company number 10659547
Status Active
Incorporation Date 8 March 2017
Company Type Private Limited Company
Address 4 CLARIDGE COURT, LOWER KINGS ROAD, BERKHAMSTED, HERTFORDSHIRE, UNITED KINGDOM, HP4 2AF
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration six events have happened. The last three records are Resolutions RES10 ‐ Resolution of allotment of securities ; Statement of capital following an allotment of shares on 30 March 2017 GBP 31.25 ; Appointment of Mr Stephen Samuel Myatt as a director on 30 March 2017. The most likely internet sites of AZERIA THERAPEUTICS LIMITED are www.azeriatherapeutics.co.uk, and www.azeria-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eight years and eleven months. Azeria Therapeutics Limited is a Private Limited Company. The company registration number is 10659547. Azeria Therapeutics Limited has been working since 08 March 2017. The present status of the company is Active. The registered address of Azeria Therapeutics Limited is 4 Claridge Court Lower Kings Road Berkhamsted Hertfordshire United Kingdom Hp4 2af. . CARROLL, Jason Scott is a Director of the company. MISCAMPBELL, Ian is a Director of the company. MYATT, Stephen Samuel is a Director of the company. PARKER, Elisabeth Maria, Dr is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
CARROLL, Jason Scott
Appointed Date: 08 March 2017
52 years old

Director
MISCAMPBELL, Ian
Appointed Date: 11 March 2017
64 years old

Director
MYATT, Stephen Samuel
Appointed Date: 30 March 2017
44 years old

Director
PARKER, Elisabeth Maria, Dr
Appointed Date: 30 March 2017
55 years old

Persons With Significant Control

Jason Scott Carroll
Notified on: 8 March 2017
52 years old
Nature of control: Ownership of shares – 75% or more

AZERIA THERAPEUTICS LIMITED Events

24 Apr 2017
Resolutions
  • RES10 ‐ Resolution of allotment of securities

07 Apr 2017
Statement of capital following an allotment of shares on 30 March 2017
  • GBP 31.25

07 Apr 2017
Appointment of Mr Stephen Samuel Myatt as a director on 30 March 2017
07 Apr 2017
Appointment of Dr Elisabeth Maria Parker as a director on 30 March 2017
07 Apr 2017
Appointment of Mr Ian Miscampbell as a director on 11 March 2017
08 Mar 2017
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2017-03-08
  • GBP 3.825